ALBI (Albumin-Bilirubin) Grade for Hepatocellular Carcinoma (HCC)
ورودیهای بالینی بیمار
حداقل ۱ — حداکثر ۶ • واحد: g/L
حداقل ۳ — حداکثر ۵۰۰ • واحد: μmol/L
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Grade 1-10–-2.6
- Grade 2-2.6–-1.39
- Grade 3-1.39–10
The ALBI (Albumin-Bilirubin) Grade for Hepatocellular Carcinoma (HCC) calculates predicting survival in hepatocellular carcinoma patients based on serum albumin and bilirubin concentrations. Key inputs include albumin. Scores guide managing portal hypertension complications, referring for liver transplant evaluation, and supportive care. Routine clinical application promotes standardized evidence-based patient management.
Clinical Guidelines & Evidence
Predicts survival in hepatocellular carcinoma patients based on serum albumin and bilirubin concentrations
Clinical Indication
The ALBI (Albumin-Bilirubin) Grade for Hepatocellular Carcinoma (HCC) is indicated for bedside clinical practice to support Predicts survival in hepatocellular carcinoma patients based on serum albumin and bilirubin concentrations. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients with decompensated liver cirrhosis, acute liver failure, portal hypertension, ascites, or end-stage liver disease awaiting organ allocation. Clinical application is indicated across Hepatology clinics, liver transplant assessment centers, gastroenterology wards, and liver ICUs.
Limitations & Contraindications
Due to muscle wasting and reduced hepatic creatine synthesis, serum creatinine routinely underestimates renal dysfunction in cirrhosis.
Clinical Pearls & Action Plan
Preventing spontaneous bacterial peritonitis (SBP), managing variceal hemorrhage, and monitoring hepatic encephalopathy are top clinical priorities.
ALBI = (log10 bilirubin × 0.66) + (albumin × -0.085), where bilirubin is in μmol/L and albumin in g/L
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| albumin | float | Yes | Serum albumin concentration(g/L) |
| bilirubin | float | Yes | Serum bilirubin concentration(μmol/L) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| -10–-2.6 | Grade 1 | Best prognosis |
| -2.6–-1.39 | Grade 2 | Intermediate prognosis |
| -1.39–10 | Grade 3 | Poorest prognosis |
Evidence-Based References (EBM)
- Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33(6):550-8. doi: 10.1200/JCO.2014.57.9151.DOI: 10.1200/JCO.2014.57.9151
- Hiraoka A, Michitaka K, Kumada T, et al. Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function. Liver Cancer. 2017;6(4):325-336. doi: 10.1159/000479984.DOI: 10.1159/000479984
- Chen B, Lin S. Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure. Medicine (Baltimore). 2017;96(24):e7142. doi: 10.1097/MD.0000000000007142.DOI: 10.1097/MD.0000000000007142